DSM revises biologics license with Valentis
DSM Biologics has dissolved its relationship with Qiagen and Valentis regarding the pAlliance, a consortium supplying ultra-pure, stable DNA plasmids and formulated DNA
DSM Biologics has dissolved its relationship with Qiagen and Valentis regarding the pAlliance, a consortium supplying ultra-pure, stable DNA plasmids and formulated DNA
Great Lakes Fine Chemicals has invested $8 million ($6.7m) in a program aimed at upgrading its pharmaceutical ingredient manufacturing facilities in Holywel, Wales
There has been a steady increase in the number of diabetes-related R&D projects in recent years, and one area of particular interest is the pulmonary delivery of insulin, says a new report
Metrohm has launched a new product, called the 837 Combi Degasser, designed to remove bubbles in eluents used in ion chromatography
Switzerland's Novartis has been awarded a US patent for a novel means of extending the shelf life of pharmaceuticals. The invention describes the use of a plastic bottle made from a polymeric material that is impregnated with an antioxidant